Maria-Jacobi-Gasse 1, Media Quarter Marx 3.4, A-1030 Wien |  | Tel.: +43 1 – 715 72 67

We use the worldwide first self-organizing human heart organoids to reinvent cardiac drug discovery. is a recently founded drug discovery company focusing on the development of a high-throughput 3D screening platform tackeling cardiomyopathies, cardiotoxicity and heart failure. Our core technology is based on the world-wide first, self-organizing cardiac organoids (cardioids) which resemble the human physiology of a human heart chamber in a way that allows for the cost-efficient and large scale in-vitro analysis of crucial clinical parameters associated with various cardiac diseases. The cardioid-based screening platform has the potential to radically change the current cardiovascular drug discovery paradigm.

Demo Day Pitch Video:
Play Video

Persönliches Profil